A deal announced on Monday with the pharmaceutical company GlaxoSmithKline (GSK) will manufacture up to 60 million doses of the Novavax vaccine. The vaccine is already being produced at a Fujifilm facility in Stockton-on-Tees, though the UK regulator has yet to approve
A deal announced on Monday with the pharmaceutical company GlaxoSmithKline (GSK) will manufacture up to 60 million doses of the Novavax vaccine. The vaccine is already being produced at a Fujifilm facility in Stockton-on-Tees, though the UK regulator has yet to approve
The Prime Minister confirmed an agreement with British drugmaker GlaxoSmithKline (GSK) would see doses of the coronavirus vaccine manufactured in the north east of England at the company’s Barnard Castle site. Britain secured a deal for 60 million doses of the life-saving
THE EU’s chaotic vaccine rollout effort has been dealt another crushing blow after it was revealed Novavax wa delaying signing a contract to supply its COVID-19 vaccine to the the bloc
The Health Secretary has hailed the huge “boost”. Matt Hancock said: “Really encouraging results from Novavax tonight on its efficacy against variants. We’ve ordered 60 million doses and if approved by the medicines regulator it will be another boost to the UK’s vaccination
